Eco R1 Capital, LLC Sarepta Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $58.1 Million - $84 Million	-512,513 Reduced 26.7%	1,407,322 $222 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $102 Million - $154 Million	1,086,928 Added 130.5%	1,919,835 $249 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $56.1 Million - $104 Million	832,907 New	832,907 $80.3 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $70.4 Million - $104 Million	661,345 Added 22.05%	3,660,798 $419 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $9.94 Million - $15.7 Million	131,308 Added 4.58%	2,999,453 $332 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $50.1 Million - $70.6 Million	798,511 Added 38.58%	2,868,145 $215 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $131 Million - $187 Million	2,069,634 New	2,069,634 $162 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $14.5 Million - $25.7 Million	-189,745 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $13.8 Million - $29.8 Million	189,745 New	189,745 $14.3 Million

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.